StockData

Jyong Biotech Ltd. (MENS) stock

MENSNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.86+0.06 (+3.33%)

Close on Nov 18, 2026Market cap $141.41MP/E –Yield –

Jyong Biotech cash

Cash and short-term investments held at the end of each period.

Jyong Biotech's cash was $1.18M at Dec 31, 2025. For fiscal 2025 it was $1.18M, up 1099.0% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.18M+1099.0%
FY2024Dec 31, 2024$98.00K-44.6%
FY2023Dec 31, 2023$177.00K-92.2%
FY2022Dec 31, 2022$2.27M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$1.18M–
Q4 FY2024Dec 31, 2024$98.00K–
Q4 FY2023Dec 31, 2023$177.00K–
Q4 FY2022Dec 31, 2022$2.27M–

More Jyong Biotech figures

See a number that looks wrong?